SERRATA LLC Patent applications |
Patent application number | Title | Published |
20150231136 | MDM2 INHIBITORS FOR TREATMENT OF OCULAR CONDITIONS - Provided herein are pharmaceutical compositions for the treatment of various ocular diseases characterized by unwanted cellular proliferation. The pharmaceutical compositions may comprise one or more MDM2 inhibitors, and may further comprise one or more additional therapeutic agents. Also provided are methods of use of MDM2 inhibitors and/or formulations thereof for the treatment of ocular diseases characterized by unwanted cellular proliferation. | 08-20-2015 |
20140134630 | RISK ANALYSIS FOR DISEASE DEVELOPMENT - In certain embodiments, a novel means for identifying the onset or change in level of severity of given disease states, and/or identifying a patient's risk for experiencing the onset or change in level of severity of given disease states is provided. In some embodiments, a predictive model is provided, which can be used to predict an individual's propensity for developing a given disease or for advancing to a certain stage of a given disease. | 05-15-2014 |
20130225603 | MDM2 INHIBITORS FOR TREATMENT OF OCULAR CONDITIONS - Provided herein are pharmaceutical compositions for the treatment of various ocular diseases characterized by unwanted cellular proliferation. The pharmaceutical compositions may comprise one or more MDM2 inhibitors, and may further comprise one or more additional therapeutic agents. Also provided are methods of use of MDM2 inhibitors and/or formulations thereof for the treatment of ocular diseases characterized by unwanted cellular proliferation. | 08-29-2013 |